NEWSROUND
Selected reports edited by Janet Fricker Download full article
Biliary tract cancer
Gemcitabine alone or plus cisplatin for biliary tract cancer?
A randomised phase III trial comparing cisplatin plus gemcitabine with gemcitabine alone for patients with advanced biliary tract cancer has provided evidence for a new standard treatment option for these patients. The therapeutic outcome (overall [more]